Forfivo Xl, Wellbutrin, Wellbutrin Sr, Wellbutrin Xl, Zyban, Mysimba (bupropion) is a small molecule pharmaceutical. Bupropion was first approved as Forfivo Xl on 1985-12-30. It is used to treat attention deficit disorder with hyperactivity, depressive disorder, and tobacco use disorder in the USA. It has been approved in Europe to treat obesity and overweight. The pharmaceutical is active against sodium-dependent dopamine transporter and sodium-dependent noradrenaline transporter. Wellbutrin sr's patent is valid until 2027-06-25 (FDA).
|Indication||attention deficit disorder with hyperactivity, depressive disorder, obesity, overweight, tobacco use disorder|